We are live on ! Find out more
ARQT icon

Arcutis Biotherapeutics
ARQT

63 hedge funds and large institutions have $1.02B invested in Arcutis Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

13% more funds holding

Funds holding: 56 → 63 (+7)

2.52% more ownership

Funds ownership: 88.51% → 91.03% (+2.5%)

0% less capital invested

Capital invested by funds: $1.02B → $1.02B (-$3.69M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
63
Holders Change
+7
Holders Change %
+12.5%
% of All Funds
1.27%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
11
Increased
31
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.1M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.56M
4
Northern Trust
Northern Trust
Illinois
+$2.19M
5
State Street
State Street
Massachusetts
+$2.11M

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$4.96M
2
VC
Vivo Capital
California
-$4.7M
3
PC
Polar Capital
United Kingdom
-$2.67M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.02M
5
Renaissance Technologies
Renaissance Technologies
New York
-$838K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$990K +$593K +22,205 +192%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$802K +$349K +13,066 +91%
Stifel Financial
28
Stifel Financial
Missouri
$696K +$78K +2,921 +14%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$641K +$384K +14,376 +192%
Swiss National Bank
30
Swiss National Bank
Switzerland
$624K – – –
Norges Bank
31
Norges Bank
Norway
$619K +$564K +21,116 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$600K – – –
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$497K +$159K +5,944 +54%
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$469K – – –
Citadel Advisors
35
Citadel Advisors
Florida
$450K -$474K -17,739 -54%
MS
36
Maven Securities
Jersey
$433K +$401K +15,000 New
DCM
37
Dupont Capital Management
Delaware
$389K +$354K +13,268 New
VEA
38
Virtus ETF Advisers
New York
$354K -$43.7K -1,637 -12%
MFS
39
Mirabella Financial Services
United Kingdom
$343K +$312K +11,691 New
TRCT
40
Tower Research Capital (TRC)
New York
$332K +$261K +9,756 +616%
Jane Street
41
Jane Street
New York
$321K +$293K +10,959 New
AIG
42
American International Group
New York
$317K +$134K +5,013 +86%
Citigroup
43
Citigroup
New York
$290K +$184K +6,873 +228%
Deutsche Bank
44
Deutsche Bank
Germany
$288K +$136K +5,090 +108%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$286K +$261K +9,776 New
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$275K – – –
MIM
47
MetLife Investment Management
New Jersey
$242K +$77.5K +2,902 +54%
JP Morgan Chase
48
JP Morgan Chase
New York
$209K +$94.6K +3,540 +111%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$166K +$50.3K +1,883 +50%
Bank of America
50
Bank of America
North Carolina
$132K +$19.9K +743 +20%
1
2
3

ARQT Hedge Fund Activity: Q3 2020 in Review

63 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Arcutis Biotherapeutics (ARQT) for Q3 2020, worth a combined $1.02B — down 0.36% from $1.02B a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ARQT positions and 4 closed out — a net gain of 7 holders — while 31 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $13.1M. The largest seller was Omega Fund Management, cutting an estimated $4.96M.

  • 63 institutional investors held Arcutis Biotherapeutics (ARQT) as of Q3 2020, up from 56 in Q2 2020.
  • Funds reported $1.02B of Arcutis Biotherapeutics stock for Q3 2020, down 0.36% quarter-over-quarter.
  • 11 funds opened new Arcutis Biotherapeutics positions in Q3 2020 and 4 closed out, a net change of +7 holders.
  • The largest Arcutis Biotherapeutics buyer in Q3 2020 was BlackRock, an estimated $13.1M added.
  • The largest Arcutis Biotherapeutics seller in Q3 2020 was Omega Fund Management, an estimated $4.96M sold.

Based on aggregated 13F filings for Q3 2020.